supporting apheresis and manufacturing processes in the cgt space
Published 2 years ago • 88 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:40
the changing landscape of hospital-based cell and gene therapy manufacturing
-
2:14
the need for standardization in cell and gene therapy manufacturing
-
1:07
establishing chain of identity & chain of custody standards in cgt manufacturing
-
1:29
cmc challenges in cell and gene therapy manufacturing
-
2:52
developing manufacturing systems for cell and gene therapies
-
44:30
panel: gene therapy manufacturing
-
59:32
the current state of investment in cell and gene therapy
-
1:18:21
industrialization of cell therapy manufacturing workshop
-
1:58
cell & gene therapy trailblazers - process development - chapter 1: ‘diagnose to de-risk’
-
2:27
importance of scalable cell therapy manufacturing processes
-
3:05
cell therapy manufacturing explained
-
16:31
a view on streamlining the cell and gene therapy manufacturing
-
10:19
process development of a closed car-t manufacturing process
-
1:26
what are the benefits of in-process control in cell therapy manufacturing processes ?
-
2:49
cell therapy manufacturing process: how to design your facility
-
0:31
why cell therapy manufacturing process needs automation
-
31:16
manufacturing considerations in cell therapy development | anne kantardjieff, ph.d.
-
1:02
differences in supply chains in the cgt industry
-
45:10
industry input, skill standards, and cell & gene therapy course content
-
11:12
technology-ready processes for gene therapy manufacturing 2.0
-
2:23
cell and gene therapy manufacturing innovation
-
3:05
car-t cell therapy: apheresis